Skip to content

Source filing unavailable

Q1 2012 · —
Revenue$34.00Kno prior Q1 2011 on file
Net income—
EPS Diluted-$2.71no prior Q1 2011 on file
Operating Income-$3,983,000—
Margins · derived
Operating margin-11714.7%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q1 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR